Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Studies: Widely Used Diabetes Drugs Seem Safe for the Heart

June 9, 2015 1:04 pm | by Marilynn Marchione, AP Medical Writer | News | Comments

Some widely used diabetes medicines help control blood sugar without the heart risks suggested by earlier research, new studies find. Read more..

Birth Month May Dictate Diseases You Get, Study Says

June 9, 2015 12:59 pm | by Seth Augenstein, Digital Reporter | News | Comments

People looking to their birth astrological sign to know the future might just as well consult hospital records. Birth months are associated with certain high and low risks of specific ailments, according to a large data-driven study published in the Journal of the American Medical Informatics Association. Read more...


Scientists Show Antitumor Agent Can Be Activated by Natural Response to Cell Stress

June 9, 2015 12:45 pm | by Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found that a drug candidate with anticancer potential can be activated by one of the body’s natural responses to cellular stress. Once activated, the agent can kill prostate cancer cells. Read more...


Engineers Crack DNA Code of Autoimmune Disorders

June 9, 2015 12:19 pm | by Seth Augenstein, Digital Reporter | News | Comments

Autoimmune diseases such as lupus and psoriasis are baffling – when the body attacks itself, there appears to be no cure or therapy that can fully stop it. But scientists say they’ve figured out an “unexpectedly general” set of rules that determine how molecules become prone to patterns of self-destructive behavior, according to a study published this week by a UCLA team in the journal Nature Materials. Read more...


Merck Launches First New Antibiotic in 15 Years in U.K.

June 9, 2015 8:34 am | by Ryan Bushey, Associate Editor | Articles | Comments

This is the first oral treatment to be released from this class of drugs since 2001. Read more...


Teva Accuses Mylan of 'Desperate Attempt' to Suppress Bid

June 9, 2015 8:33 am | by The Associated Press | News | Comments

Both Mylan and Israeli based Teva Pharmaceutical Industries are looking to consolidate in an increasingly competitive generic drug industry. Read more...


Biochemists Devise New Technique for Blueprinting Cell Membrane Proteins

June 9, 2015 8:33 am | by Trinity College Dublin | News | Comments

These blueprints can show weaknesses that allow drug developers to draw up specific battle plans in the fight against diseases and infections. Read more...


O Blood Type Means More Gray Matter, Less Alzheimer's, British Researchers Say

June 9, 2015 8:32 am | by Seth Augenstein, Digital Reporter | Articles | Comments

The increased volume of brain could mean more protection against degenerative diseases like Alzheimer’s. Read more...


Global Diabetes Rate Nearly Doubles in 20 Years

June 9, 2015 8:32 am | by Stephanie Guzowski, Editor | News | Comments

As the obesity rate continues to rise, so does the prevalence of diabetes and its complications — and developing countries are becoming just as affected as first-world countries, according to a new study, which analyzed more than 35,000 data sources in 188 countries. Read more...


Virus Evolution, Human Behavior Shape Global Patterns of Flu Movement

June 9, 2015 8:31 am | by University of Cambridge | News | Comments

An international team of researchers report surprising differences between the various types of seasonal flu virus, which they show to be due to the rate at which the different viruses evolve. Read more...


Braeburn Pharmaceuticals: Positive Results From Phase 3 Opioid Addiction Study

June 8, 2015 11:06 am | News | Comments

Braeburn Pharmaceuticals, an Apple Tree Partners company, today reported positive topline results from the Phase 3 double-blind, double-dummy clinical study of Probuphine, the investigational subdermal implant containing buprenorphine HCl for the long-term maintenance treatment of opioid addiction. Read more...


Massachusetts General Hospital Launches Phase 2 Trial of BCG Vaccine to Reverse Type 1 Diabetes

June 8, 2015 10:51 am | by Massachusetts General Hospital | News | Comments

A phase 2 clinical trial testing the ability of the generic vaccine bacillus Calmette-Guérin (BCG) to reverse advanced type 1 diabetes has received approval from the U.S. Food and Drug Administration (FDA). Read more...


Filings Suggest Georgia Can't Explain Cloudy Execution Drug

June 8, 2015 10:08 am | by Kate Brumback, Associated Press | News | Comments

Georgia prison officials have pointed to cold storage temperatures as "the most likely cause" of the cloudiness in a lethal injection drug that halted an execution at the last minute - but they have since revealed testing indicating it might not have been to blame. Read more..

Amgen Completes Enrollment in Large Cardiovascular Trial of Repatha

June 8, 2015 10:03 am | News | Comments

Approximately 27,500 patients are now fully enrolled in FOURIER trial designed to evaluate if Repatha in combination with statin therapy reduces the risk of cardiovascular events. Read more...


Protein Associated with Cancer Silences the Biological Clock

June 8, 2015 9:52 am | by Tim Stephens, University of California, Santa Cruz | News | Comments

A new study led by UC Santa Cruz researchers has found that a protein associated with cancer cells is a powerful suppressor of the biological clock that drives the daily ("circadian") rhythms of cells throughout the body. The discovery, published in the June 4 issue of Molecular Cell, adds to a growing body of evidence suggesting a link between cancer and disruption of circadian rhythms. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.